title: Just Toxicity, or Toxicity As a Biomarker of Efficacy of Ramucirumab in Breast Cancer?
authors.affiliation: School of Medicine, Chungnam National University and Chungnam National University Hospital; and Cancer Research Institute, Chungnam National University, Daejeon, Republic of Korea cymed@cnu.ac.kr.
authors.forename: Hyo Jin
authors.initials: HJ
authors.lastname: Lee
authors.affiliation: School of Medicine, Chungnam National University and Chungnam National University Hospital; and Cancer Research Institute, Chungnam National University, Daejeon, Republic of Korea.
authors.forename: Hyewon
authors.initials: H
authors.lastname: Ryu
authors.affiliation: School of Medicine, Chungnam National University and Chungnam National University Hospital; and Cancer Research Institute, Chungnam National University, Daejeon, Republic of Korea.
authors.forename: Yoon Seok
authors.initials: YS
authors.lastname: Choi
authors.affiliation: School of Medicine, Chungnam National University and Chungnam National University Hospital; and Cancer Research Institute, Chungnam National University, Daejeon, Republic of Korea.
authors.forename: Ik-Chan
authors.initials: IC
authors.lastname: Song
authors.affiliation: School of Medicine, Chungnam National University and Chungnam National University Hospital; and Cancer Research Institute, Chungnam National University, Daejeon, Republic of Korea.
authors.forename: Hwan-Jung
authors.initials: HJ
authors.lastname: Yun
authors.affiliation: School of Medicine, Chungnam National University and Chungnam National University Hospital; and Cancer Research Institute, Chungnam National University, Daejeon, Republic of Korea.
authors.forename: Deog-Yeon
authors.initials: DY
authors.lastname: Jo
authors.affiliation: School of Medicine, Chungnam National University and Chungnam National University Hospital; and Cancer Research Institute, Chungnam National University, Daejeon, Republic of Korea.
authors.forename: Samyong
authors.initials: S
authors.lastname: Kim
mesh_terms: D000911:Antibodies, Monoclonal / Q000008:administration & dosage* / Q000009:adverse effects*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000473:pathology*; D005260:Female; D006801:Humans; D009364:Neoplasm Recurrence, Local / Q000188:drug therapy*
chemical_list: D000911:Antibodies, Monoclonal